Chesapeake Urology Associates Welcomes Chesapeake Oncology-Hematology Associates
In an exciting development for healthcare in Maryland, Chesapeake Urology Associates (CUA) has officially merged with Chesapeake Oncology-Hematology Associates (COHA), known for its long-standing commitment to compassionate cancer care. This partnership is aimed at enhancing the delivery of integrated medical oncology and urology services on the robust OneOncology platform.
A New Era of Integrated Care
COHA has made significant contributions to patient care in Maryland for over 25 years, providing personalized services through five medical oncologists and two advanced practice providers across three locations: Columbia, Glen Burnie, and Annapolis. With the integration into CUA, the vision is clear: to offer a seamless experience for patients through combined urology and oncology services, ensuring they receive comprehensive care without the need to travel far.
Dr. Gayatri Nimmagadda, president of COHA, emphasized the importance of this milestone in enhancing community access to world-class cancer care. She stated, "With the unique opportunity to collaborate with leading specialty medical practices across the nation as part of the OneOncology platform, we can ensure that patients receive top-notch care while staying close to home. This collaboration fosters a multidisciplinary approach to treating genitourinary cancers, ultimately benefiting patients who require both urological and oncological interventions."
Strengthening the Community Healthcare Framework
The OneOncology platform is designed to create synergy by integrating urology and medical oncology practices, resulting in improved patient outcomes through enhanced quality of care and cost-effectiveness. Brad Lerner, MD, president of Chesapeake Urology, explained that nearly 40% of urology patients face a cancer diagnosis. Bringing together urologists, medical oncologists, and radiation oncologists within an integrated framework is expected to significantly uplift patient care throughout central Maryland.
With this merger, patients will have better access to precision diagnostics and innovative therapies, including clinical trials that can lead to more effective treatment options. COHA’s resources now include operational and clinical support from UUG and OneOncology, expanding their capacity to deliver comprehensive, patient-centered cancer care. This synergy not only focuses on immediate medical needs but also emphasizes ongoing support and resources to enhance patient quality of life.
Future of Cancer Care in the Region
As this partnership unfolds, UUG, OneOncology, and CUA are committed to increasing access to vital cancer services in Maryland. The wellness of the community is at the forefront of this initiative, and there are plans for investments aimed at expanding service offerings. The goal is to empower medical professionals with the necessary tools and insights for effective patient management, bolstering the ability to adapt to the evolving challenges in community health care.
The COHA clinics, which provide care at:
- - Columbia: 5450 Knoll North Drive, Suite 140
- - Glen Burnie: Tate Center, 305 Hospital Drive
- - Annapolis: 129 Lubrano Drive, Suite 201
are now poised to operate within a more resource-rich environment, leading to potential improvements in both operational efficiency and patient satisfaction.
Through this innovative collaboration, patients in Maryland can expect a higher standard of cancer care that combines the strengths of multiple disciplines into a cohesive treatment plan. The integration of services on the OneOncology platform means that quality cancer care can now be more accessible, efficient, and effective, right where patients live and work.
In conclusion, the coalition between Chesapeake Oncology-Hematology Associates and Chesapeake Urology Associates marks a significant step forward in the quest for integrated healthcare solutions that cater to the needs of the community, ensuring that patients always remain at the heart of all efforts.